ACE ALERA CLINICAL CHEMISTRY SYSTEM, ACE GLUCOSE REAGENT, ACE ION SELECTIVE ELECTRODE (ISE) MODULE

Hexokinase, Glucose

ALFA WASSERMANN DIAGNOSTIC TECHNOLOGIES, INC.

The following data is part of a premarket notification filed by Alfa Wassermann Diagnostic Technologies, Inc. with the FDA for Ace Alera Clinical Chemistry System, Ace Glucose Reagent, Ace Ion Selective Electrode (ise) Module.

Pre-market Notification Details

Device IDK123018
510k NumberK123018
Device Name:ACE ALERA CLINICAL CHEMISTRY SYSTEM, ACE GLUCOSE REAGENT, ACE ION SELECTIVE ELECTRODE (ISE) MODULE
ClassificationHexokinase, Glucose
Applicant ALFA WASSERMANN DIAGNOSTIC TECHNOLOGIES, INC. 4 HENDERSON DRIVE West Caldwell,  NJ  07006
ContactHyman Katz Ph.d.
CorrespondentHyman Katz Ph.d.
ALFA WASSERMANN DIAGNOSTIC TECHNOLOGIES, INC. 4 HENDERSON DRIVE West Caldwell,  NJ  07006
Product CodeCFR  
Subsequent Product CodeCEM
Subsequent Product CodeCGZ
Subsequent Product CodeJGS
Subsequent Product CodeJJE
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2012-09-28
Decision Date2013-04-23
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00857969006693 K123018 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.